Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 17PE 22-28 literaturePubMed · Observational2023

Gestational Diabetes in Migrants: Prevalence and Metabolic Profile During Pregnancy: A Retrospective Italian Cohort Study.

The study found that 47% of migrant women screened had gestational diabetes, compared to 37% of Italian women, highlighting a significant public health concern.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the pe 22-28 corpus
1
Preclinical
15
Observational · this one
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study analyzed the prevalence and metabolic profiles of gestational diabetes (GDM) in a cohort of 4186 pregnant women, including 22% migrants, screened at a hospital in Italy from 2014 to 2022. It found that GDM prevalence was higher in migrant women (47%) compared to Italian women (37%), with migrants also exhibiting worse metabolic control. No therapeutic claims are made.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
GDM prevalence was higher in migrants (47%) vs. Italians (37%), p<0.001.2023

Abstract

The authors’ words, as PubMed supplied them

<h4>Aims</h4>Migration flows have brought many women of childbearing age to Italy, some of whom are from ethnic groups at high risk for gestational diabetes (GDM). However, the extent of migration and its impact on the prevalence of GDM in Italy are little known.<h4>Materials and methods</h4>We retrospectively analysed data from 4186 pregnant women (22% migrants) screened for GDM at the University Hospital of Pisa between 2014 and 2022. We compared GDM prevalence and risk factors between Italian and migrant women, and assessed metabolic profiles in those with GDM.<h4>Results</h4>The proportion of migrant women increased from 8% in 2014 to 25% in 2022 (p < 0.001). Italian women were older (36 ± 5 vs. 32 ± 6, p < 0.001), while migrant women had higher pre-gestational BMI (24 [22-28] vs. 23 [21-26] kg/m<sup>2</sup>, p < 0.001) and more frequently a history of previous GDM (12% vs. 9%, p < 0.001). GDM prevalence was higher in migrants (47% vs. 37%, p < 0.001). Among GDM women, migrants had worse metabolic control (HbA1c 5.5% ± 2.5% vs. 5.2% ± 2.8%, p < 0.001), and more frequently required basal-bolus insulin therapy (6% vs. 3%, p = 0.003).<h4>Conclusions</h4>Nowadays, one in four pregnant women is a migrant. Tailored dietary interventions should be encouraged in this population due to the higher risk of GDM and worse metabolic control.

Background

The paper addresses the prevalence of gestational diabetes among migrant populations, a topic of growing concern given the increasing migration rates and associated health implications. Prior studies have indicated varying prevalence rates of gestational diabetes in different populations, but data specifically focusing on migrants is limited. This study aims to fill that gap by providing insights into the metabolic profiles of this demographic during pregnancy.

Methods

The study utilized a retrospective design, analyzing medical records of pregnant migrants in Italy. The specific population size (n) and duration of the study were not reported in the abstract. The primary outcome measures included the prevalence of gestational diabetes and associated metabolic parameters, although exact metrics were not provided.

Results

Not reported in abstract.

Interpretation

Without specific numeric findings, it is challenging to compare this study's outcomes to existing literature on gestational diabetes. The lack of reported effect sizes limits the ability to assess clinical significance. Additionally, the retrospective nature of the study may introduce confounding variables that could affect the reliability of the conclusions drawn.

Key findings

  • Not reported in abstract.

Limitations

  • Retrospective design may introduce bias.
  • Specific numeric outcomes not reported.
  • Sample size not disclosed.
  • Lacks longitudinal data to assess long-term implications.

Elsewhere in the PE 22-28 corpus

BClinical outcomes and mortality risk among inborn and referred newborns admitted to hospitals in Kenyabiorxiv-preprint · 2026 · Unadjusted mortality among referred newborns was 29.0% compared to 11.3% in those inborn, p<0.001.HumanBAssessment of ageing using global mass-spectrometry based metabolomics: A cross-cohort longitudinal study in the UK and Irelandbiorxiv-preprint · 2026 · Each standard deviation higher metabolomic age acceleration (∼5 years) was associated with 43% higher mortality risk.HumanASafety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.Human vaccines & immunotherapeutics · 2026 · Peak antibody titers observed 14 d after COVAC-2 vaccination.HumanBPhysical activity, sleep, dietary habits, and screen time in Bogotá's children post-pandemic lockdown: a mixed-methods study.International journal of qualitative studies on health and well-being · 2026 · 66% met ≥3 days/week of moderate physical activity.HumanBEngaging youth in health and research in rural Cambodia: a qualitative study.Global health action · 2026HumanBInfection outbreaks caused by carbapenemase-producing Enterobacterales: An epidemiological surveillance study in public hospitals in Chile, 2017-2024.Global epidemiology · 2026 · n=5000 · Median outbreak size: pandemic 7 cases.Human